Tag: RESTORE study
Revalesio receives US FDA fast-track designation for RNS60 in acute ischaemic...
Revalesio announced recently that the US Food and Drug Administration (FDA) has granted a fast-track designation to RNS60—the company’s lead investigational therapy—for the treatment...
Mainstay announces positive outcomes in “landmark” restorative neurostimulation trial
Mainstay Medical has announced the publication of positive one-year primary assessment results from the RESTORE randomised clinical trial evaluating ReActiv8 for the treatment of...
Mainstay Medical announces completion of US enrolment in RESTORE clinical trial
Mainstay Medical has announced the completion of enrolment in its RESTORE randomised clinical study of ReActiv8 for the treatment of intractable chronic low back...
Enspire announces US$17.6 million Series B financing to advance DBS plus...
Enspire DBS Therapy recently announced that it has raised US$17.6 million of committed capital in a Series B financing led by existing investor Cleveland Clinic Innovations....
